Impact BiomedicalIBO
13F holders, Q2 2026 (June 30)22holders +2
3new positions
0sold out
1famous investor
$0.46avg. 13F price*
At the end of Q2 2026, 22 institutions reported holding Impact Biomedical Inc. (IBO) in their 13F filings, up 2 from Q1 2026. 3 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($546K), Vanguard Capital Management LLC ($372K) and State Street Corp. ($280K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Impact Biomedical Inc.
- CUSIP
- 45259L205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $34K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 178,860 shares bought and 66,835 shares sold, net +112,025 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Geode Capital Management, LLC | 0.00% | Reduce -0.7% | 1,185,163 | $546K |
| Vanguard Capital Management LLC | 0.00% | Add +14.2% | 808,689 | $372K |
| State Street Corp. | 0.00% | No change | 607,897 | $280K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 589,428 | $271K |
| BlackRock, Inc. | 0.00% | No change | 259,946 | $120K |
| Northern Trust Corp. | 0.00% | Reduce -3.5% | 235,475 | $108K |
| Citadel Advisors | 0.00% | New | 49,567 | $23K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 32,201 | $15K |
| Jane Street Group, LLC | 0.00% | New | 24,528 | $11K |
| Two Sigma Investments, LP | 0.00% | Reduce -54.1% | 17,191 | $8K |
| Mason & Associates Inc | 0.00% | No change | 10,000 | $5K |
| Morgan Stanley | 0.00% | Add +0.1% | 9,285 | $4K |
| UBS Group AG | 0.00% | Reduce -92.6% | 2,400 | $1K |
| Global Trust Asset Management, LLC | 0.00% | No change | 1,818 | $836 |
| FMR LLC | 0.00% | Add +0.7% | 292 | $134 |
| Wells Fargo & Company | 0.00% | No change | 224 | $103 |
| NFSG Corp | 0.00% | No change | 86 | $40 |
| Burk Holdings LLC | 0.00% | No change | 27 | $12 |
| Danske Bank A/S | 0.00% | No change | 3 | $1 |
| Citigroup Inc. | 0.00% | Reduce -99.7% | 1 | $0 |
| Royal Bank of Canada | 0.00% | No change | 32 | $0 |
| Blue Trust, Inc. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is IBO's weight in each manager's 13F, not the share of Impact Biomedical Inc. the manager owns.